Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

Novartis building

Novartis weighs in on biosimilar naming debate

Files petition urging FDA to keep system where biosimilars share a name with the original drug

- PMLiVE

Change at the top as Levin leaves Teva

CEO resigns amid company-wide restructure

- PMLiVE

Janssen submits blood cancer drug in EU

Seeks EMA approval for ibrutinib

- PMLiVE

Former Ketchum head joins Luther Pendragon

Avril Lee becomes director at the corporate communications consultancy

- PMLiVE

AZ takes severe asthma antibody into phase III

Benralizumab shows promise in clinical trials

Shire appoints finance-focused board member

Dominic Blakemore is group finance director of Compass Group

- PMLiVE

FDA raises awareness of misleading drug ads

E-learning course to help HCPS and students learn how to report untruthful promotion

- PMLiVE

Driving good practice in homecare

The release of new professional standards looks to underpin the quality, and continued rise, of homecare services in the UK

- PMLiVE

Havas’ UK Nurofen campaign to cost £3m

Reckitt Benckiser rolls out TV advertisements in time for flu and cold season

Sanofi reception

Sanofi returns to growth in Q3

Diabetes products and Genzyme help company overcome patent cliff

- PMLiVE

Pfizer sales down but oncology shows promise

Toll of patent expiries continues

- PMLiVE

Incivek decline forces Vertex job cuts

370 positions to be axed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links